Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5428)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2015 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pollicino T, Koumbi L. Role natural killer group 2D-ligand interactions in hepatitis B infection. World J Hepatol 2015; 7(6): 819-824 [PMID: 25937859 DOI: 10.4254/wjh.v7.i6.819] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i6/819.htm |
| Number | Citing Articles |
| 1 |
Ratna S. Wijaya, Scott A. Read, Stephen Schibeci, Shuanglin Han, Mahmoud K. Azardaryany, David van der Poorten, Rita Lin, Lawrence Yuen, Vincent Lam, Mark W. Douglas, Jacob George, Golo Ahlenstiel. Expansion of dysfunctional CD56‐CD16+ NK cells in chronic hepatitis B patients. Liver International 2021; 41(5): 969 doi: 10.1111/liv.14784
|
| 2 |
Ganesh Selvaraj Duraisamy, Dattatry Bhosale, Ivana Lipenská, Ivana Huvarova, Daniel Růžek, Marc P. Windisch, Andrew D. Miller. Advanced Therapeutics, Vaccinations, and Precision Medicine in the Treatment and Management of Chronic Hepatitis B Viral Infections; Where Are We and Where Are We Going?. Viruses 2020; 12(9): 998 doi: 10.3390/v12090998
|
| 3 |
Sheng-Tao Cheng, Hua Tang, Ji-Hua Ren, Xiang Chen, Ai-Long Huang, Juan Chen, Chiaho Shih. Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo. PLOS ONE 2017; 12(6): e0179605 doi: 10.1371/journal.pone.0179605
|
| 4 |
Xiao-Xiao Wang, Xiao-Ben Pan, Jin-Chao Han, Xu Cong, Qian Jin, Xiang-Sha Kong, Lai Wei, Bo Feng. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication. Hepatobiliary & Pancreatic Diseases International 2018; 17(3): 233 doi: 10.1016/j.hbpd.2018.03.010
|
| 5 |
Li Wang, Kai Wang, Zhi-Qiang Zou. Crosstalk between innate and adaptive immunity in hepatitis B virus infection. World Journal of Hepatology 2015; 7(30): 2980-2991 doi: 10.4254/wjh.v7.i30.2980
|
| 6 |
Zhi-Qiang Zou, Li Wang, Kai Wang, Ji-Guang Yu. Innate immune targets of hepatitis B virus infection. World Journal of Hepatology 2016; 8(17): 716-725 doi: 10.4254/wjh.v8.i17.716
|
| 7 |
Yadong Wang, Wei Wang, Chuan Shen, Yong Wang, Mingjing Jiao, Weiyan Yu, Hongzhu Yin, Xiaobo Shang, Qianfei Liang, Caiyan Zhao. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-00221-9
|
| 8 |
Jian Wang, Cun-Di Li, Lin Sun. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma. Biomolecules 2020; 10(2): 301 doi: 10.3390/biom10020301
|
| 9 |
Alma Chávez-Blanco, Rommel Chacón-Salinas, Guadalupe Dominguez-Gomez, Aurora Gonzalez-Fierro, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Catalina Trejo-Becerril, Alfonso Duenas-Gonzalez. Viral inhibitors of NKG2D ligands for tumor surveillance. Expert Opinion on Therapeutic Targets 2016; 20(11): 1375 doi: 10.1080/14728222.2016.1202928
|